Problem statement: Answer the MCQ question.
Query: What is the human ether-à-go-go related gene (hERG) inhibition at 10uM of a compound with the SMILES Nc1nc2c(nc(Br)n2[C@@H]2O[C@@H]3COP(=O)([O-])O[C@H]3[C@H]2O)c(=O)[nH]1.[Na+]?
Constraint: You must return none, one or more options from a, b, c, d, or e without using any additional words.
Options:
[a] -4.770
[b] 6.602
[c] 2.297
[d] 6.664
[e] -18.920
Answer: c. 2.297%.
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: What is the {herg_central_at_10uM__names__noun} of a {#compound|drug!} with the {SMILES__description} {SMILES#}?
Constraint: You must return none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{herg_central_at_10uM%SMILES%}
Answer: {%multiple_choice_result}. {herg_central_at_10uM#}{herg_central_at_10uM__units}.
Nc1nc2c(nc(Br)n2[C@@H]2O[C@@H]3COP(=O)([O-])O[C@H]3[C@H]2O)c(=O)[nH]1.[Na+]
Nc1nc2c(nc(Br)n2[C@@H]2O[C@@H]3COP(=O)([O-])O[C@H]3[C@H]2O)c(=O)[nH]1.[Na+]
sodium;9-[(4aR,6R,7R,7aS)-7-hydroxy-2-oxido-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl]-2-amino-8-bromo-1H-purin-6-one